Direct oral anticoagulants (DOACs) are available for nonvalvular atrial fibrillation patients.
The advantage of DOACs is that regular anticoagulation monitoring is not required …

Aims Direct oral anticoagulants (DOACs) are increasingly used for stroke prevention in atrial
fibrillation. However, little is known about the association between medication adherence …

Few studies assessed the association between major adverse cardiovascular events and
adherence to warfarin and direct oral anticoagulants (DOACs) in patients with atrial …

Background Adherence to direct oral anticoagulants (DOACs) remains a concern among
non‐valvular atrial fibrillation (AF) patients. We aimed to assess patterns of adherence with …

Background The impact of adherence to direct oral anticoagulants (DOACs) is unknown. We
aimed to assess the effects of preceding anticoagulation treatment on neurologic severity at …

Background A high degree of adherence to direct oral anticoagulants is essential for
reducing the risk of ischaemic stroke and systemic embolism in patients with atrial fibrillation …

Background Direct oral anticoagulants (DOACs) are widely used in patients with nonvalvular
atrial fibrillation for stroke prevention. However, long‐term adherence to DOACs and clinical …

Background The direct oral anticoagulants (DOACs) reduce the risk of stroke in moderate to
high-risk patients with non-valvular atrial fibrillation (AF). Yet, concerns remain regarding its …

Objective Medication adherence is essential for effective stroke prevention in patients with
atrial fibrillation (AF). We aimed to assess whether adherence to direct oral anticoagulants …

Objectives: Our study examined the impact of adherence to novel oral anticoagulants
[NOACs-dabigatran and rivaroxaban] on ischemic-stroke (IS), major-bleeding (MB), deep …